Autor/in Buggisch, Peter Sarrazin, Christoph Klinker, Hartwig 3 Hinrichsen, Holger 2 Teuber, Gerlinde 2 Weich, Viola 2 Aslan, Nuray 1 Bergk, Alexandra 1 Boecher, Wulf O 1 Chung, Tje Lin 1 Ciner, Ayse 1 Cornberg, Markus 1 Dikopoulos, Nektarios 1 Encke, Jens 1 Gerlach, Tilman 1 Goeser, Tobias 1 Halangk, Juliane 1 Herrmann, Eva 1 Jaeckel, Elmar 1 Kubitschke, Anne 1 Landt, Olfert 1 Manns, Michael P 1 Mueller, Tobias 1 Möller, Bernd 1 Neumann, Konrad 1 Puhl, Gero 1 Schlaphoff, Verena 1 Schwendy, Susanne 1 Spengler, Ulrich 1 Thimme, Robert 1 Wedemeyer, Heiner 1 Wiegand, Johannes 1 Zeuzem, Stefan 1 alle zeigenListe einklappen
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. Sarrazin, Christoph Schwendy, Susanne Möller, Bernd Dikopoulos, Nektarios Buggisch, Peter Encke, Jens Teuber, Gerlinde 2011 - Forschungsinformationssystem des UKE
The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection. Weich, Viola Herrmann, Eva Chung, Tje Lin Sarrazin, Christoph Hinrichsen, Holger Buggisch, Peter Gerlach, Tilman 2011 - Forschungsinformationssystem des UKE
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. Halangk, Juliane Sarrazin, Christoph Neumann, Konrad Puhl, Gero Mueller, Tobias Teuber, Gerlinde Klinker, Hartwig 2008 - Forschungsinformationssystem des UKE
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C. Wiegand, Johannes Cornberg, Markus Aslan, Nuray Schlaphoff, Verena Sarrazin, Christoph Kubitschke, Anne Buggisch, Peter 2007 - Forschungsinformationssystem des UKE
